1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDISC2: The Quest Awards is sponsored by California Institute for Regenerative Medicine. The Quest Awards program promotes the discovery of promising new stem cell-based technologies that could be translated into broad use and ultimately improve patient care. Includes specific interest in heart failure treatments and cardiac tissue engineering.
Get alerted about grants like this
Save a search for “California Institute for Regenerative Medicine” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
CIRM Grant Applications Now Open: DISC5 and CLIN2 | Stem Cell Research The California Institute for Regenerative Medicine (CIRM) has opened applications for its DISC5 and CLIN2 funding programs, offering major opportunities for UCLA investigators in gene, cell, and regenerative medicine. Applications are due January 30, 2026 at 2pm PST Consult with Experts at the UCLA Health Alpha Clinic on your Applications Drs.
Noah Federman and Laurie Shaker-Irwin lead the CIRM-funded UCLA Alpha Clinic efforts in regenerative medicine, gene, and cell therapy clinical research at UCLA. The Alpha Clinic partners with the CTSI and the BSCRC to assist researchers as they navigate UCLA resources to succeed in the application process for CIRM funding.
Resources include those on the discovery and translational side for developing a lead candidate to advance to further testing. On the clinical research side, resources include, amongst many, clinical protocol development, regulatory and FDA affairs, research coordination, and statistical analysis and data management.
In order to best discuss the expertise and resource needs of investigators for their CIRM grant applications, please complete the CIRM Funding Opportunity Interest Survey and we will follow up with you and/or your designee directly to schedule a meeting.
CLIN2: Support for Regenerative Medicine Clinical Trials CIRM’s CLIN2 program funds Phase 1, 2, and 3 clinical trials , including pivotal trials, for regenerative medicine therapies addressing significant unmet medical needs. The program provides not only financial support but also access to CIRM’s internal experts and external advisors to help teams advance toward marketing approval with strong plans for access and affordability.
CLIN2 creates clinical research opportunities that are otherwise limited within traditional funding pathways. DISC5: Foundational and Exploratory Research Funding The DISC5 program supports innovative, early-stage research led by interdisciplinary investigator teams aiming to overcome fundamental knowledge gaps or bottlenecks in stem cell biology and regenerative medicine.
Projects should aim to advance basic understanding of human stem/progenitor cells use stem cells to uncover disease mechanisms or enable therapeutic/biomarker discovery address key scientific or technical challenges in stem cells gene therapy, or other regenerative approaches improve applicability of regenerative medicine to diverse populations. This grant is up to $2. 5M per award (including indirects) for up to 3-year s.
Teams must include two California-based investigators from different labs. A Course in Stem Cell Medicine: From Scientific Research to Patient Care Workshop: Navigating the INTERACT Meeting and Communicating with the FDA View All News and Highlights
Based on current listing details, eligibility includes: California-based non-profit and for-profit organizations; non-California organizations may be eligible if research is conducted in CA. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $1,500,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is June 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.